Home Qinglan Jichuang Completes Tens of Millions RMB Angel Financing to Accelerate Commercialization of Cindigo Ori™, the World’s First Integrated Flexible and Rigid Endoscopy Platform

Qinglan Jichuang Completes Tens of Millions RMB Angel Financing to Accelerate Commercialization of Cindigo Ori™, the World’s First Integrated Flexible and Rigid Endoscopy Platform

Oct 28, 2024 08:00 CST Updated 08:00
BIOCHING CAPITAL

Early-Stage Venture Capital Institutions in the Healthcare Field

G&G Capital

Healthcare Industry Financial Advisory Firm

CDIG

Equity Investment, Investment Management Institutions

VCBeat has learned at the earliest opportunity that,A Leading Domestic Innovative Enterprise in High-Performance Intelligent Endoscopy—Qinglan Jichuang Medical Equipment (Chengdu) Co., Ltd. (hereinafter referred to as “Qinglan Jichuang”) recently announced the successful completion of its angel round financing, amounting to tens of millions of RMB. This round of financing was led byCDIGLead Investor,Guanghua Wutong, BIOCHING CAPITALandBiocity Jingchuangwith follow-on investments from well-known investment institutions.G&G Capitalwill serve as the financial advisor for subsequent financing rounds.


The funds raised will be primarily used to accelerate the commercialization of Cindigo Ori™, the world’s first integrated platform for flexible and rigid endoscopy, and to further optimize the product portfolio of Cindigo Ori™’s full range of flexible and rigid endoscopes.


1729907879867.png


Since 2019, the domestic endoscope market in China has experienced rapid growth. According to the latest bidding data from 2024, the market share of domestic rigid endoscope brands exceeded 40% in the first half of the year, marking significant achievements in import substitution for high-performance rigid endoscopes by Chinese brands. Meanwhile, the market share of domestic flexible endoscopes remains below 15%, indicating substantial potential for import substitution in the flexible endoscope market.


Qinglan Jichuang is an innovative enterprise dedicated to the research, development, and production of high-performance intelligent endoscopes. Leveraging a robust R&D team and advanced technological platforms, the company is committed to providing high-quality products and services to the healthcare industry, thereby driving innovation and advancement in endoscopic technology.


Qinglan Jichuang’s founding team brings together multiple experts in the field of high-performance flexible endoscopy in China, dedicated to launching Cindigo Ori™, the industry’s first integrated platform for flexible and rigid endoscopes. This innovation aims to meet the demand for multi-endoscope combined surgeries in large public hospitals across China, while also addressing the need for efficient, multifunctional equipment in primary care hospitals.


Cindigo Ori™ is set to become China’s first flexible endoscopy platform supporting native 4K imaging and native 4K optical zoom. Its innovations in scope maneuverability and system reliability have been acclaimed by the industry as the “Qinglan Solution,” aiming to provide Chinese clinicians with a user experience comparable to that of high-end flexible endoscopes from leading imported brands.


Chen Yunliang, Founder of Qinglan Jichuangstated: “We extend our heartfelt gratitude to the investors who participated in this round of financing. The success of this fundraising not only provides solid financial support for our product R&D and market expansion, but also lays the foundation for accelerating technological iteration, advancing our global layout, and building brand influence. Seizing this opportunity, we will further promote the intelligent development of high-end endoscopy products and the widespread adoption of advanced endoscopic technologies, provide specialized solutions for endoscopy departments, and contribute to the global healthcare cause.”

 

Chengdu Science and Technology Innovation Investment Groupstated: “We are delighted to support Qinglan Jichuang’s angel financing round and facilitate the establishment of its headquarters in Chengdu. In recent years, driven by technological innovation, policy support, and market expansion, China’s domestic endoscopy industry has demonstrated significant growth potential and promising prospects. The rising market share of domestically produced endoscopes underscores a strong trend of import substitution. We will work closely with Dr. Chen Yunliang and his core team to advance the intelligent development of high-end domestic endoscopic products and promote the widespread adoption of advanced endoscopic technologies, providing integrated, innovative, and efficient comprehensive solutions for endoscopy departments.”